HEADER HYDROLASE/HYDROLASE INHIBITOR 07-OCT-10 3P4U TITLE CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 IN COMPLEX WITH AC-VEID-CHO TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-6; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: UNP REISIDUES 24-179; COMPND 5 SYNONYM: CASP-6, APOPTOTIC PROTEASE MCH-2, CASPASE-6 SUBUNIT P18, COMPND 6 CASPASE-6 SUBUNIT P11; COMPND 7 EC: 3.4.22.59; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CASPASE-6; COMPND 11 CHAIN: B, D; COMPND 12 FRAGMENT: UNP RESIDUES 193-293; COMPND 13 SYNONYM: CASP-6, APOPTOTIC PROTEASE MCH-2, CASPASE-6 SUBUNIT P18, COMPND 14 CASPASE-6 SUBUNIT P11; COMPND 15 EC: 3.4.22.59; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: AC-VEID-CHO INHIBITOR; COMPND 19 CHAIN: E, F; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP6, MCH2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: CASP6, MCH2; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: ROSETTA; SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 OTHER_DETAILS: SYNTHETIC CONSTRUCT KEYWDS PROTEASE, CASPASE, HUNTINGTON'S DISEASE, COMPETITIVE INHIBITION, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.MUELLER,M.B.A.C.LAMERS,A.J.RITCHIE,C.DOMINGUEZ,I.MUNOZ,M.MAILLARD, AUTHOR 2 A.KISELYOV REVDAT 2 02-DEC-15 3P4U 1 REMARK REVDAT 1 28-SEP-11 3P4U 0 JRNL AUTH I.MUELLER,M.B.A.C.LAMERS,A.J.RITCHIE,C.DOMINGUEZ,I.MUNOZ, JRNL AUTH 2 M.MAILLARD,A.KISELYOV JRNL TITL CRYSTAL STRUCTURES OF ACTIVE AND INHIBITOR-BOUND HUMAN CASP6 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 40238 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.151 REMARK 3 R VALUE (WORKING SET) : 0.150 REMARK 3 FREE R VALUE : 0.185 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2030 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1793 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 59.33 REMARK 3 BIN R VALUE (WORKING SET) : 0.1960 REMARK 3 BIN FREE R VALUE SET COUNT : 99 REMARK 3 BIN FREE R VALUE : 0.2570 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3879 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 613 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 10.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.23000 REMARK 3 B22 (A**2) : 0.35000 REMARK 3 B33 (A**2) : -0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.12000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.127 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.072 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.407 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4016 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2720 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5437 ; 1.050 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6606 ; 0.785 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 496 ; 5.943 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 186 ;30.295 ;23.280 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 657 ;11.534 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;15.526 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 598 ; 0.076 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4445 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 870 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2442 ; 0.393 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 990 ; 0.075 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3925 ; 0.781 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1574 ; 1.303 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1504 ; 2.182 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 3P4U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-DEC-10. REMARK 100 THE RCSB ID CODE IS RCSB061957. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40267 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 19.904 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10200 REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 68.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.31300 REMARK 200 R SYM FOR SHELL (I) : 0.31300 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M CALCIUM ACETATE, 0.1 M SODIUM REMARK 280 CACODYLATE PH 5.5 AND 12% PEG 8000, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.75000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAINS A & B & C & D REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-ACETYL-L-VALYL-L-ALPHA-GLUTAMYL-N-[(2S)-1-CARBOXY-3- REMARK 400 HYDROXYPROPAN-2-YL]-L-ISOLEUCINAMIDE IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-ACETYL-L-VALYL-L-ALPHA-GLUTAMYL-N-[(2S)-1-CARBOXY-3- REMARK 400 HYDROXYPROPAN-2-YL]-L-ISOLEUCINAMIDE REMARK 400 CHAIN: E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 23 REMARK 465 ALA A 24 REMARK 465 PHE A 25 REMARK 465 TYR A 26 REMARK 465 LYS A 27 REMARK 465 ARG A 28 REMARK 465 GLU A 29 REMARK 465 MET A 30 REMARK 465 ASP A 176 REMARK 465 VAL A 177 REMARK 465 VAL A 178 REMARK 465 ASP A 179 REMARK 465 ASP B 193 REMARK 465 ALA B 194 REMARK 465 ALA B 195 REMARK 465 SER B 196 REMARK 465 VAL B 197 REMARK 465 SER B 292 REMARK 465 ASN B 293 REMARK 465 ARG B 294 REMARK 465 HIS B 295 REMARK 465 HIS B 296 REMARK 465 HIS B 297 REMARK 465 HIS B 298 REMARK 465 HIS B 299 REMARK 465 HIS B 300 REMARK 465 ASP C 23 REMARK 465 ALA C 24 REMARK 465 PHE C 25 REMARK 465 TYR C 26 REMARK 465 LYS C 27 REMARK 465 ARG C 28 REMARK 465 GLU C 29 REMARK 465 MET C 30 REMARK 465 ASP C 176 REMARK 465 VAL C 177 REMARK 465 VAL C 178 REMARK 465 ASP C 179 REMARK 465 ASP D 193 REMARK 465 ALA D 194 REMARK 465 ALA D 195 REMARK 465 SER D 196 REMARK 465 VAL D 197 REMARK 465 SER D 292 REMARK 465 ASN D 293 REMARK 465 ARG D 294 REMARK 465 HIS D 295 REMARK 465 HIS D 296 REMARK 465 HIS D 297 REMARK 465 HIS D 298 REMARK 465 HIS D 299 REMARK 465 HIS D 300 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 38 CG CD CE NZ REMARK 470 ARG A 42 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 54 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 76 CG CD NE CZ NH1 NH2 REMARK 470 CAS A 87 AS CE1 CE2 REMARK 470 GLU A 94 CG CD OE1 OE2 REMARK 470 GLU A 123 CG CD OE1 OE2 REMARK 470 GLN A 137 CG CD OE1 NE2 REMARK 470 LYS B 265 CG CD CE NZ REMARK 470 LYS C 38 CG CD CE NZ REMARK 470 ARG C 42 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 65 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 94 CG CD OE1 OE2 REMARK 470 LYS C 99 CG CD CE NZ REMARK 470 GLU C 123 CG CD OE1 OE2 REMARK 470 GLN C 137 CG CD OE1 NE2 REMARK 470 LYS D 265 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP C 110 O HOH C 389 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 64 68.95 -109.11 REMARK 500 SER B 242 -47.02 -132.28 REMARK 500 ARG C 64 61.56 -112.78 REMARK 500 PHE D 288 59.88 -117.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 504 DISTANCE = 9.13 ANGSTROMS REMARK 525 HOH C 353 DISTANCE = 6.90 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF AC-VEID-CHO REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF AC-VEID-CHO REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3P45 RELATED DB: PDB REMARK 900 APO-CASPASE-6 AT PHYSIOLOGICAL PH DBREF 3P4U A 24 179 UNP P55212 CASP6_HUMAN 24 179 DBREF 3P4U B 193 293 UNP P55212 CASP6_HUMAN 193 293 DBREF 3P4U C 24 179 UNP P55212 CASP6_HUMAN 24 179 DBREF 3P4U D 193 293 UNP P55212 CASP6_HUMAN 193 293 DBREF 3P4U E 701 705 PDB 3P4U 3P4U 701 705 DBREF 3P4U F 801 805 PDB 3P4U 3P4U 801 805 SEQRES 1 A 157 ASP ALA PHE TYR LYS ARG GLU MET PHE ASP PRO ALA GLU SEQRES 2 A 157 LYS TYR LYS MET ASP HIS ARG ARG ARG GLY ILE ALA LEU SEQRES 3 A 157 ILE PHE ASN HIS GLU ARG PHE PHE TRP HIS LEU THR LEU SEQRES 4 A 157 PRO GLU ARG ARG GLY THR CAS ALA ASP ARG ASP ASN LEU SEQRES 5 A 157 THR ARG ARG PHE SER ASP LEU GLY PHE GLU VAL LYS CAS SEQRES 6 A 157 PHE ASN ASP LEU LYS ALA GLU GLU LEU LEU LEU LYS ILE SEQRES 7 A 157 HIS GLU VAL SER THR VAL SER HIS ALA ASP ALA ASP CYS SEQRES 8 A 157 PHE VAL CYS VAL PHE LEU SER HIS GLY GLU GLY ASN HIS SEQRES 9 A 157 ILE TYR ALA TYR ASP ALA LYS ILE GLU ILE GLN THR LEU SEQRES 10 A 157 THR GLY LEU PHE LYS GLY ASP LYS CYS HIS SER LEU VAL SEQRES 11 A 157 GLY LYS PRO LYS ILE PHE ILE ILE GLN ALA CYS ARG GLY SEQRES 12 A 157 ASN GLN HIS ASP VAL PRO VAL ILE PRO LEU ASP VAL VAL SEQRES 13 A 157 ASP SEQRES 1 B 108 ASP ALA ALA SER VAL TYR THR LEU PRO ALA GLY ALA ASP SEQRES 2 B 108 PHE LEU MET CYS TYR SER VAL ALA GLU GLY TYR TYR SER SEQRES 3 B 108 HIS ARG GLU THR VAL ASN GLY SER TRP TYR ILE GLN ASP SEQRES 4 B 108 LEU CYS GLU MET LEU GLY LYS TYR GLY SER SER LEU GLU SEQRES 5 B 108 PHE THR GLU LEU LEU THR LEU VAL ASN ARG LYS VAL SER SEQRES 6 B 108 GLN ARG ARG VAL ASP PHE CAS LYS ASP PRO SER ALA ILE SEQRES 7 B 108 GLY LYS LYS GLN VAL PRO CAS PHE ALA SER MET LEU THR SEQRES 8 B 108 LYS LYS LEU HIS PHE PHE PRO LYS SER ASN ARG HIS HIS SEQRES 9 B 108 HIS HIS HIS HIS SEQRES 1 C 157 ASP ALA PHE TYR LYS ARG GLU MET PHE ASP PRO ALA GLU SEQRES 2 C 157 LYS TYR LYS MET ASP HIS ARG ARG ARG GLY ILE ALA LEU SEQRES 3 C 157 ILE PHE ASN HIS GLU ARG PHE PHE TRP HIS LEU THR LEU SEQRES 4 C 157 PRO GLU ARG ARG GLY THR CAS ALA ASP ARG ASP ASN LEU SEQRES 5 C 157 THR ARG ARG PHE SER ASP LEU GLY PHE GLU VAL LYS CAS SEQRES 6 C 157 PHE ASN ASP LEU LYS ALA GLU GLU LEU LEU LEU LYS ILE SEQRES 7 C 157 HIS GLU VAL SER THR VAL SER HIS ALA ASP ALA ASP CYS SEQRES 8 C 157 PHE VAL CYS VAL PHE LEU SER HIS GLY GLU GLY ASN HIS SEQRES 9 C 157 ILE TYR ALA TYR ASP ALA LYS ILE GLU ILE GLN THR LEU SEQRES 10 C 157 THR GLY LEU PHE LYS GLY ASP LYS CYS HIS SER LEU VAL SEQRES 11 C 157 GLY LYS PRO LYS ILE PHE ILE ILE GLN ALA CYS ARG GLY SEQRES 12 C 157 ASN GLN HIS ASP VAL PRO VAL ILE PRO LEU ASP VAL VAL SEQRES 13 C 157 ASP SEQRES 1 D 108 ASP ALA ALA SER VAL TYR THR LEU PRO ALA GLY ALA ASP SEQRES 2 D 108 PHE LEU MET CYS TYR SER VAL ALA GLU GLY TYR TYR SER SEQRES 3 D 108 HIS ARG GLU THR VAL ASN GLY SER TRP TYR ILE GLN ASP SEQRES 4 D 108 LEU CYS GLU MET LEU GLY LYS TYR GLY SER SER LEU GLU SEQRES 5 D 108 PHE THR GLU LEU LEU THR LEU VAL ASN ARG LYS VAL SER SEQRES 6 D 108 GLN ARG ARG VAL ASP PHE CAS LYS ASP PRO SER ALA ILE SEQRES 7 D 108 GLY LYS LYS GLN VAL PRO CAS PHE ALA SER MET LEU THR SEQRES 8 D 108 LYS LYS LEU HIS PHE PHE PRO LYS SER ASN ARG HIS HIS SEQRES 9 D 108 HIS HIS HIS HIS SEQRES 1 E 5 ACE VAL GLU ILE ASJ SEQRES 1 F 5 ACE VAL GLU ILE ASJ MODRES 3P4U CAS A 68 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 3P4U CAS A 87 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 3P4U CAS B 264 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 3P4U CAS B 277 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 3P4U CAS C 68 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 3P4U CAS C 87 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 3P4U CAS D 264 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 3P4U CAS D 277 CYS S-(DIMETHYLARSENIC)CYSTEINE HET CAS A 68 12 HET CAS A 87 9 HET CAS B 264 9 HET CAS B 277 9 HET CAS C 68 9 HET CAS C 87 12 HET CAS D 264 9 HET CAS D 277 9 HET ACE E 701 3 HET ASJ E 705 8 HET ACE F 801 3 HET ASJ F 805 8 HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE HETNAM ACE ACETYL GROUP HETNAM ASJ (3S)-3-AMINO-4-HYDROXYBUTANOIC ACID FORMUL 1 CAS 8(C5 H12 AS N O2 S) FORMUL 5 ACE 2(C2 H4 O) FORMUL 5 ASJ 2(C4 H9 N O3) FORMUL 7 HOH *613(H2 O) HELIX 1 1 PHE A 56 THR A 60 5 5 HELIX 2 2 GLY A 66 LEU A 81 1 16 HELIX 3 3 LYS A 92 VAL A 106 1 15 HELIX 4 4 ILE A 136 LEU A 142 1 7 HELIX 5 5 CYS A 148 VAL A 152 5 5 HELIX 6 6 TRP B 227 GLY B 240 1 14 HELIX 7 7 GLU B 244 ARG B 259 1 16 HELIX 8 8 ASP B 266 ILE B 270 5 5 HELIX 9 9 PHE C 56 THR C 60 5 5 HELIX 10 10 GLY C 66 LEU C 81 1 16 HELIX 11 11 LYS C 92 VAL C 106 1 15 HELIX 12 12 ILE C 136 GLY C 141 1 6 HELIX 13 13 LEU C 142 LYS C 144 5 3 HELIX 14 14 CYS C 148 VAL C 152 5 5 HELIX 15 15 TRP D 227 GLY D 240 1 14 HELIX 16 16 GLU D 244 ARG D 259 1 16 HELIX 17 17 ASP D 266 ILE D 270 5 5 SHEET 1 A12 GLU A 84 ASN A 89 0 SHEET 2 A12 ILE A 46 ASN A 51 1 N ILE A 49 O LYS A 86 SHEET 3 A12 PHE A 114 LEU A 119 1 O VAL A 117 N LEU A 48 SHEET 4 A12 LYS A 156 GLN A 161 1 O ILE A 157 N PHE A 114 SHEET 5 A12 PHE B 206 TYR B 210 1 O CYS B 209 N PHE A 158 SHEET 6 A12 CAS B 277 SER B 280 -1 O ALA B 279 N MET B 208 SHEET 7 A12 CAS D 277 SER D 280 -1 O SER D 280 N PHE B 278 SHEET 8 A12 PHE D 206 TYR D 210 -1 N MET D 208 O ALA D 279 SHEET 9 A12 LYS C 156 GLN C 161 1 N PHE C 158 O CYS D 209 SHEET 10 A12 PHE C 114 LEU C 119 1 N PHE C 114 O ILE C 157 SHEET 11 A12 ILE C 46 ASN C 51 1 N LEU C 48 O VAL C 117 SHEET 12 A12 GLU C 84 ASN C 89 1 O PHE C 88 N ASN C 51 SHEET 1 B 3 GLY A 122 GLU A 123 0 SHEET 2 B 3 HIS A 126 TYR A 128 -1 O HIS A 126 N GLU A 123 SHEET 3 B 3 LYS A 133 GLU A 135 -1 O ILE A 134 N ILE A 127 SHEET 1 C 2 PRO A 171 VAL A 172 0 SHEET 2 C 2 LEU D 200 PRO D 201 -1 O LEU D 200 N VAL A 172 SHEET 1 D 2 LEU B 200 PRO B 201 0 SHEET 2 D 2 PRO C 171 VAL C 172 -1 O VAL C 172 N LEU B 200 SHEET 1 E 3 GLY B 225 SER B 226 0 SHEET 2 E 3 HIS B 219 GLU B 221 -1 N GLU B 221 O GLY B 225 SHEET 3 E 3 GLU E 703 ILE E 704 -1 O GLU E 703 N ARG B 220 SHEET 1 F 3 GLY C 122 GLU C 123 0 SHEET 2 F 3 HIS C 126 TYR C 128 -1 O HIS C 126 N GLU C 123 SHEET 3 F 3 LYS C 133 GLU C 135 -1 O ILE C 134 N ILE C 127 SHEET 1 G 3 GLY D 225 SER D 226 0 SHEET 2 G 3 HIS D 219 GLU D 221 -1 N GLU D 221 O GLY D 225 SHEET 3 G 3 GLU F 803 ILE F 804 -1 O GLU F 803 N ARG D 220 LINK C THR A 67 N CAS A 68 1555 1555 1.34 LINK C CAS A 68 N ALA A 69 1555 1555 1.33 LINK C LYS A 86 N CAS A 87 1555 1555 1.34 LINK C CAS A 87 N PHE A 88 1555 1555 1.34 LINK C PHE B 263 N CAS B 264 1555 1555 1.33 LINK C CAS B 264 N LYS B 265 1555 1555 1.34 LINK C PRO B 276 N CAS B 277 1555 1555 1.33 LINK C CAS B 277 N PHE B 278 1555 1555 1.33 LINK C THR C 67 N CAS C 68 1555 1555 1.33 LINK C CAS C 68 N ALA C 69 1555 1555 1.34 LINK C LYS C 86 N CAS C 87 1555 1555 1.33 LINK C CAS C 87 N PHE C 88 1555 1555 1.33 LINK C PHE D 263 N CAS D 264 1555 1555 1.33 LINK C CAS D 264 N LYS D 265 1555 1555 1.33 LINK C PRO D 276 N CAS D 277 1555 1555 1.32 LINK C CAS D 277 N PHE D 278 1555 1555 1.33 LINK C ACE E 701 N VAL E 702 1555 1555 1.34 LINK C ACE F 801 N VAL F 802 1555 1555 1.34 LINK C ILE E 704 N ASJ E 705 1555 1555 1.33 LINK C ILE F 804 N ASJ F 805 1555 1555 1.33 LINK SG CYS C 163 C ASJ F 805 1555 1555 1.88 LINK SG CYS A 163 C ASJ E 705 1555 1555 2.09 SITE 1 AC1 13 ARG A 64 ARG A 65 HIS A 121 GLY A 122 SITE 2 AC1 13 GLN A 161 CYS A 163 TYR B 217 SER B 218 SITE 3 AC1 13 HIS B 219 ARG B 220 GLU B 221 THR B 222 SITE 4 AC1 13 CAS B 264 SITE 1 AC2 13 ARG C 64 HIS C 121 GLN C 161 CYS C 163 SITE 2 AC2 13 HOH C 311 TYR D 217 SER D 218 HIS D 219 SITE 3 AC2 13 ARG D 220 GLU D 221 THR D 222 CAS D 264 SITE 4 AC2 13 HOH D 422 CRYST1 55.455 89.500 61.245 90.00 111.73 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018033 0.000000 0.007187 0.00000 SCALE2 0.000000 0.011173 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017577 0.00000